Maynard, MA, United States of America

Ronald R Forand


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald R. Forand

Introduction

Ronald R. Forand is a notable inventor based in Maynard, MA (US). He has made significant contributions to the field of assay processes, particularly in the area of competitive protein binding radioassays. His work has implications for the detection of vital components such as vitamin B12 and serum folate.

Latest Patents

Forand holds a patent for an assay process that utilizes non-boiling denaturation. The patent, titled "Assay process with non-boiling denaturation - Competitive protein binding radioassay for sera (or cell) vitamin B.sub.12 and/or serum folate," describes a method that operates in a highly alkaline environment. This innovative approach allows for the separation of target components from serum without the need for boiling, which is consistent with the requirements of such assays. The process then reduces the pH to a range of 8-10 to facilitate competitive protein binding, enabling the detection of both protein-bound and unbound groups of radioactively tagged target components.

Career Highlights

Ronald R. Forand is associated with Rohm and Haas Company, where he has applied his expertise in assay processes. His work has contributed to advancements in the field, particularly in improving the accuracy and efficiency of assays used in medical and research settings.

Collaborations

Forand has collaborated with Edward T. Menz, further enhancing the innovative work being done in the field of assay processes. Their combined efforts have led to significant advancements in the detection of essential vitamins and other target components.

Conclusion

Ronald R. Forand's contributions to the field of assay processes demonstrate his commitment to innovation and excellence. His patent and work at Rohm and Haas Company highlight the importance of developing efficient methods for detecting vital components in serum.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…